- Home
- IMMP vs DENN Comparison
IMMP vs DENN Comparison
Compare IMMP & DENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- DENN
- Stock Information
- Founded
- IMMP 1987
- DENN 1953
- Country
- IMMP Australia
- DENN United States
- Employees
- IMMP N/A
- DENN N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- DENN Restaurants
- Sector
- IMMP Health Care
- DENN Consumer Discretionary
- Exchange
- IMMP Nasdaq
- DENN Nasdaq
- Market Cap
- IMMP 211.1M
- DENN 203.4M
- IPO Year
- IMMP N/A
- DENN 1989
- Fundamental
- Price
- IMMP $1.86
- DENN $4.36
- Analyst Decision
- IMMP Buy
- DENN Strong Buy
- Analyst Count
- IMMP 2
- DENN 6
- Target Price
- IMMP $8.50
- DENN $7.46
- AVG Volume (30 Days)
- IMMP 648.0K
- DENN 1.2M
- Earning Date
- IMMP 05-16-2025
- DENN 05-05-2025
- Dividend Yield
- IMMP N/A
- DENN N/A
- EPS Growth
- IMMP N/A
- DENN N/A
- EPS
- IMMP N/A
- DENN 0.33
- Revenue
- IMMP $3,019,249.00
- DENN $453,997,000.00
- Revenue This Year
- IMMP $11.25
- DENN $5.81
- Revenue Next Year
- IMMP $10.22
- DENN $2.50
- P/E Ratio
- IMMP N/A
- DENN $13.20
- Revenue Growth
- IMMP 24.11
- DENN N/A
- 52 Week Low
- IMMP $1.32
- DENN $2.85
- 52 Week High
- IMMP $3.34
- DENN $8.30
- Technical
- Relative Strength Index (RSI)
- IMMP 53.43
- DENN 68.91
- Support Level
- IMMP $1.44
- DENN $3.64
- Resistance Level
- IMMP $2.71
- DENN $3.93
- Average True Range (ATR)
- IMMP 0.17
- DENN 0.24
- MACD
- IMMP 0.05
- DENN 0.14
- Stochastic Oscillator
- IMMP 29.75
- DENN 84.71
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About DENN Denny's Corporation
Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.